Related Experiment Video
Updated: Sep 16, 2025

Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
Applying a mobile intervention for chronic insomnia in routine care: Study protocol for a multicenter randomized
Daa Un Moon1,2, Jeonghun Kim3, Jeyoung Hannah Sun3
1Department of Psychiatry and Neurosciences, Charité Campus Mitte, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany.
This study evaluates a mobile cognitive behavioral therapy for insomnia (CBT-I) app, "SleepQ," in a clinical trial. Findings will assess the effectiveness of digital CBT-I for chronic insomnia treatment.
Area of Science:
- Digital health interventions
- Sleep medicine
- Behavioral therapy
Background:
- Cognitive behavioral therapy for insomnia (CBT-I) is a first-line treatment, but access is limited.
- Digital CBT-I (dCBT-I) offers a scalable solution to address treatment gaps.
- Real-world evidence for mobile dCBT-I effectiveness is needed.
Purpose of the Study:
- To examine the effectiveness of the mobile dCBT-I intervention,
- SleepQ,
- in a routine clinical setting.
- To evaluate the clinical implementation of digital therapeutics for insomnia.
- To inform the integration of mobile-based CBT-I into routine care.
Main Methods:
- A multicenter, two-arm, open-label, randomized controlled trial.
- 120 adults with chronic insomnia assigned to mobile dCBT-I or a waitlist control.
- Primary outcome: Insomnia Severity Index change at 6 weeks.
Main Results:
- The study is ongoing; results are not yet available.
- Primary and secondary outcomes will be assessed at 6 weeks.
- Long-term effects will be evaluated at 3- and 6-month follow-ups.
Conclusions:
- This trial will evaluate the effectiveness of mobile dCBT-I for chronic insomnia in routine clinical care.
- Findings will contribute to the broader understanding of digital therapeutics for insomnia.
- Results will guide the integration of mobile-based CBT-I into standard practice.
More Related Videos
Related Concept Videos
Management of Insomnia
Insomnia
Multiple factors contribute...
Blind Procedures
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
What is an Experiment?
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

